Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
story of the week
Published in Cardiology and
1 other channel

Journal Scan / Research · October 05, 2016

Cardiac Biomarkers as a Prognostic Tool for Mortality in Type 2 Diabetes

JAMA Cardiology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Benjamin Scirica MD

JAMA Cardiology
Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical Trial
JAMA Cardiol 2016 Sep 28;[EPub Ahead of Print], BM Scirica, DL Bhatt, E Braunwald, I Raz, MA Cavender, K Im, O Mosenzon, JA Udell, B Hirshberg, PS Pollack, PG Steg, P Jarolim, DA Morrow

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated